The addition of IMiDs for patients with daratumumab-refractory multiple myeloma can overcome refractoriness to both agents

Maria Gavriatopoulou; Efstathios Kastritis; Ioannis Ntanasis‐Stathopoulos; Despina Fotiou; Μαρία Ρούσσου; Magdalini Migkou; Dimitrios C. Ziogas; Nikolaos Kanellias; Evangelos Terpos; Meletios A Dimopoulos

doi:10.1182/blood-2017-10-809293

Related publications

Article2020

The Addition of IMiDs for Patients with Daratumumab-Refractory Multiple Myeloma Can Overcome Refractoriness to Both Agents

Despina Fotiou, Maria Gavriatopoulou, Ioannis Ntanasis‐Stathopoulos, Magdalini Migkou, Nikolaos Kanellias, Panagiotis Malandrakis, Foteini Theodorakakou, Ioanna Dialoupi, Evangelos Eleutherakis‐Papaiakovou, Μαρία Ρούσσου, Evangelos Terpos, Meletios A Dimopoulos, Efstathios Kastritis

Article2021

Evaluation of Efficacy and Immune Modulation Associated with the Addition of IMiDs to Daratumumab Backbone in Patients Refractory to Both Drug Classes

Despina Fotiou, Ioannis V. Kostopoulos, Maria Krevvata, Maria Gavriatopoulou, Ioannis Ntanasis‐Stathopoulos, Pantelis Roussakis, Chrysanthi Panteli, Panagiotis Malandrakis, Magdalini Migkou, Nikolaos Kanellias, Evangelos Eleutherakis Papaiakovou, Foteini Theodorakakou, Evangelos Terpos, Ourania Tsitsilonis, Meletios A Dimopoulos, Efstathios Kastritis

Letter2024

Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic activity

Ioannis V. Kostopoulos, Despina Fotiou, Maria Gavriatopoulou, Pantelis Rousakis, Ioannis Ntanasis‐Stathopoulos, Chrysanthi Panteli, Panagiotis Malandrakis, Magdalini Migkou, Nikolaos Angelis, Nikolaos Kanellias, Evangelos Eleutherakis‐Papaiakovou, Foteini Theodorakakou, Maria Krevvata, Evangelos Terpos, Meletios A Dimopoulos, Ourania Tsitsilonis, Efstathios Kastritis

Article2023

PB2124: EFFICACY AND IMMUNE MODULATION OF DARATUMUMAB PLUS IMID COMBINATION IN PATIENTS REFRACTORY TO BOTH AGENTS“

Ioannis V. Kostopoulos, Despina Fotiou, Maria Krevvata, Maria Gavriatopoulou, Ioannis Ntanasis‐Stathopoulos, Pantelis Roussakis, Chrysanthi Panteli, Panos Malandrakis, Nikolaos Kanellias, Magdalini Migkou, Evangelos Eleftherakis Papaiakovou, Foteini Theodorakakou, Evangelos Terpos, Meletios A Dimopoulos, Ourania Tsitsiloni, Efstathios Kastritis

Article2021

Efficacy and Safety of Durvalumab Combined with Daratumumab in Daratumumab-Refractory Multiple Myeloma Patients

Kristine A. Frerichs, Christie P.M. Verkleij, Meletios A Dimopoulos, Jhon A. Marin Soto, Sonja Zweegman, Mary H. Young, Kathryn J. Newhall, Tuna Mutis, Niels W.C.J. van de Donk